1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ALNYLAM PHARMACEUTICALS INC
Alnylam Pharmaceuticals Inc XNAS: ALNY
452.00 -1.54 (-0.34%)
751.5K
XNAS Volume

XNAS 05 Sep, 2025 5:30 PM (EDT)

Board Meeting
The board meeting for Alnylam Pharmaceuticals Inc is scheduled for today, for the purpose of Morgan Stanley 23rd Annual Global Healthcare Conference See details

Alnylam Pharmaceuticals Inc - ALNY - stock price prediction, stock price target, analyst ratings from 31 analysts

Alnylam Pharmaceuticals Inc has a share price target of US$ 421, revenue growth forecast of 55.7%, and profit growth estimate of 145.6% for FY25, based on top 31 analyst calls.